MFDS — authorised 13 November 2013
- Marketing authorisation holder: PHARMACYCLICS INC
- Status: likely_approved
🇰🇷 Imbruvica in South Korea
MFDS authorised Imbruvica on 13 November 2013
Marketing authorisation
Imbruvica in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Imbruvica approved in South Korea?
Yes. MFDS authorised it on 13 November 2013.
Who is the marketing authorisation holder for Imbruvica in South Korea?
PHARMACYCLICS INC holds the South Korean marketing authorisation.